Healthcare
Arbutus Biopharma Corporation (ABUS)
69/ 100 Tessera Quality Score
Snapshot
- Market Cap
- $899M
- P/E
- 5.4
- Sector Median P/E
- 24.4
- F-Score
- 6/9
- ROIC
- 61.9%
- FCF Yield
- -3.8%
With a Tessera Quality Score of 68, ABUS ranks in the top 50% of Healthcare stocks tracked. The stock's P/E of 5.4 sits 78% below the sector median of 24.4. Piotroski F-Score is 6/9; trailing ROIC is 61.9%.
Sector Peers
- Vertex Pharmaceuticals Incorporated (VRTX)Mkt Cap: $114.6B · FCF: 30.3%
- Verona Pharma plc (VRNA)Mkt Cap: $72.7B · FCF: -43.6%
- Regeneron Pharmaceuticals, Inc. (REGN)Mkt Cap: $62.8B · FCF: 27.9%
- argenx SE (ARGX)Mkt Cap: $54.3B · FCF: 17.2%
- Seagen Inc. (SGEN)Mkt Cap: $43.2B · FCF: -30.5%